Weight gain in craniopharyngioma - A model for hypothalamic obesity

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 2, 2006, Pages 121-127

  Ahmet, Alexandra ^a   Blaser, Susan ^a   Stephens, Derek ^a   Guger, Sharon ^a   Rutka, James T ^a   Hamilton, Jill ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Body mass index; Child; Craniopharyngioma; Obesity; Weight gain

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE;

ANTHROPOMETRY; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DIABETES INSIPIDUS; FEMALE; HUMAN; HYDROCEPHALUS; HYPOPITUITARISM; HYPOTHALAMUS LESION; INAPPROPRIATE VASOPRESSIN SECRETION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE REGRESSION; NEUROENDOCRINOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PREOPERATIVE PERIOD; RADIOLOGICAL PARAMETERS; RISK ASSESSMENT; RISK FACTOR; TUMOR RECURRENCE; WEIGHT GAIN;

EID: 33644775540     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.2.121     Document Type: Article

References (24)

1. Carmel PW. Craniopharyngiomas. In: Rengachary SS, ed. Neurosurgery. New York: McGraw-Hill, 1996; 1389-1400.
2. DeVile CJ, Grant DB, Hayward RD, Stanhope R. Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 1996; 75: 108-114.
3. Curtis J, Daneman D, Hoffman HJ, Ehrlich RM. The endocrine outcome after surgical removal of craniopharyngiomas. Pediatr Neurosurg 1994; 21 (Suppl 1): 24-27.
4. Di Vito L, Broglio F, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Ghigo E, Arvat E. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of erogenous somatostatin in humans. Clin Endocrinol 2002; 56: 643-648.
5. Rutka JT, Hoffman HJ, Drake JM, Humphreys RP. Suprasellar and sellar tumors in childhood and adolescence. Neurosurg Clin North Am 1992; 3: 803-820.
6. Hoffman HJ, De Silva M, Humphreys RP, Drake JM, Smith ML, Blaser SI. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 1992; 76: 47-52.
7. Sorva R. Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 1988; 77: 587-592.
8. Dietz R. Childhood Obesity, 3rd Ed. Philadelphia, PA: Lippincott, Williams and Wilkins, 1999.
9. Muller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kuhl J, Gutjahr P, Sorensen N, Calaminus G. Obesity after childhood craniopharyngioma-German multicenter study on preoperative risk factors and quality of life. Klin Pädiatr 2001; 213: 244-249.
10. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327: 1350-1355.
11. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 1998; 101: 497-504.
12. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997; 337: 869-873.
13. Bulow B, Attewell R, Hagmar L, Malmstrom P, Nordstrom CH, Erfurth EM. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab 1998; 83: 3897-3904.
14. de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, Stanhope R. Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 1996; 81: 2734-2737.
15. 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J Endocrinol Invest 2001; 24: RC7-9.
16. Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sorensen N. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 2004; 89: 3298-3305.
17. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL. CDC Growth Charts: United States Vital and Health Statistics of the Centers for Disease Control and Prevention. National Center for Health Statistics, 2000; 314: 1-27.
18. Bray GA, York DA. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 1979; 59: 719-809.
19. Duff JM, Meyer FB, Ilstrup DM, Laws ER, Schleck CD, Scheithauer BW. Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery 2000; 46: 291-302.
20. Muller HL, Heinrich M, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sorensen N. Perioperative dexamethasone treatment in childhood craniopharyngioma-influence on short-term and long-term weight gain. Exp Clin Endocrinol Diabetes 2003; 111: 330-334.
21. Muller HL, Faldum A, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sorensen N. Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma. Klin Pädiatr 2003; 215: 310-314.
22. Inoue S, Bray GA. An autonomic hypothesis for hypothalamic obesity. Life Sci 1979; 25: 561-566.
23. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 1999; 135: 162-168.
24. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2003; 88: 2586-2592.